13F Holdings
中文EN

CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Hospital & Medical Service Plans · Nasdaq · SEC CIK 1801170 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY54.5%
TTM net income YoY121.3%
TTM EPS YoY119.6%
Revenue 3-yr CAGR14.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin0.5%
Net margin0.5%
FCF margin4.8%
EBITDA margin0.5%

Returns

ROE3.4%
ROA1.9%
ROIC (approx.)7.2%
Asset turnover4.17x

Leverage & solvency

Liabilities / assets48.1%
Debt / equity0.00x
Current ratio1.55x
Interest coverage—

Cash quality & payout

Operating cash flow / net income10.87x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.92B$1.37B$1.26B$1.10B$1.47B
Gross profit——$257.33M$22.73M-$79.18M
SG&A expense$214.27M$176.48M$183.09M$203.68M$185.29M
Operating income-$85.53M-$45.75M-$205.33M-$286.66M-$636.99M
Interest expense$0$0$7,000$1.33M$3.19M
Pretax income-$85.55M-$43.01M-$213.36M——
Income tax$0$0$0$0$0
Net income-$85.55M-$43.01M-$213.36M-$339.57M-$587.76M
EBITDA-$83.84M-$44.42M-$202.82M-$285.48M-$635.75M
EPS (basic)——-0.44-0.71-1.42
EPS (diluted)——-0.44-0.71-1.42
Weighted avg. shares (diluted)511.97M490.02M482.18M476.24M412.92M
Banking
Deposits$14.60M$14.60M$14.70M$14.30M$11.10M
Balance sheet
Cash & equivalents$78.30M$194.54M$122.86M$186.21M$299.97M
Short-term investments$23.13M$27.00M$100.70M$189.50M$21.13M
Current assets$307.86M$343.12M$427.97M$625.00M$752.55M
PP&E, net$6.38M$5.31M$5.08M$5.75M$2.29M
Goodwill——$0$11.75M$1.24M
Total assets$541.01M$580.74M$570.67M$808.62M$950.80M
Current liabilities$208.82M$213.52M$261.12M$431.51M$371.90M
Short-term debt————$0
Long-term debt———$0$19.94M
Total debt———$0$19.94M
Total liabilities$232.31M$239.60M$284.28M$451.73M$410.76M
Shareholders' equity$308.70M$341.14M$286.39M$356.89M$535.41M
Net debt———-$186.21M-$280.03M
Cash flow statement
Operating cash flow-$66.93M$34.84M-$144.66M-$203.93M-$282.33M
Capital expenditure$2.04M$1.56M$584,000$4.47M$723,000
Free cash flow-$68.98M$33.29M-$145.25M-$208.39M-$283.05M
Investing cash flow$4.08M$565,000$140.01M$95.13M-$435.45M
Financing cash flow-$53.38M-$17.36M-$5.07M-$4.96M$925.39M
Depreciation & amortization$1.69M$1.33M$2.51M$1.19M$1.25M
Stock-based compensation$103.66M$114.33M$140.93M$164.31M$163.72M
Share buybacks$18.30M$1.77M$0$0$147,000

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.